• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性肺癌:一家机构对50例患者的经验

Lung cancer in women: a single institution experience with 50 patients.

作者信息

Babacan Nalan Akgul, Yucel Birsen, Kilickap Saadettin, Seker Mehmet Metin, Kacan Turgut, Olcas Ilknur Koc, Eren Ayfer Ay, Odabas Hatice

机构信息

Departments of Medical Oncology, University of Cumhuriyet, SIVAS, Turkey E-mail :

出版信息

Asian Pac J Cancer Prev. 2014;15(1):151-4. doi: 10.7314/apjcp.2014.15.1.151.

DOI:10.7314/apjcp.2014.15.1.151
PMID:24528017
Abstract

BACKGROUND

Lung cancer is the most common cause of cancer-related death worldwide. The incidence of lung cancer is aproximately 7-8 thousand percent in Turkish women. In this study, we aimed to evaluate the clinical, pathological properties and survival data of female patients with lung cancer who were treated in our center.

MATERIALS AND METHODS

From 2007 to 2012, 50 women with lung cancer were enrolled. Patient data were evaluated retrospectively.

RESULTS

The median age was 61 (40-81). Forty patients (80%) were diagnosed with non small cell lung cancer (NSCLC), 10 patients (20%) were small cell carcinoma (SCC). Twelve (24%) patients were smokers and 13 of 16 non-smokers had a history of exposure to asbestos. The most common histologic subtype was adenocarcinoma (46%) and this accounted for 71% in patients with exposure to asbestos. The most common initial Eastern Cooperative Oncology Group (ECOG) performance score was 1 (24 patients, 48%) and initial stage was IV (25 patients, 50%) in the study group. During the median 15 months (1-96 months) followup period: 1 year overall survival (OS) was 68%, 2year overall survival was 36% and the median survival time was 19 months. According to univariate analysis, poor ECOG performance status, advanced stage, anemia and weight loss at time of diagnosis were negative prognostic factors. However, adenocarcinoma sub-type was a positive prognostic factor.

CONCLUSIONS

In this study NSCLC sub-type, poor ECOG performance score, advanced stage, anemia and weight loss were prognostic factors in Turkish women with lung cancer.

摘要

背景

肺癌是全球癌症相关死亡的最常见原因。土耳其女性肺癌发病率约为7 - 8千分之一。在本研究中,我们旨在评估在我们中心接受治疗的女性肺癌患者的临床、病理特征及生存数据。

材料与方法

2007年至2012年,纳入50例女性肺癌患者。对患者数据进行回顾性评估。

结果

中位年龄为61岁(40 - 81岁)。40例(80%)患者被诊断为非小细胞肺癌(NSCLC),10例(20%)为小细胞癌(SCC)。12例(24%)患者吸烟,16例不吸烟者中有13例有石棉接触史。最常见的组织学亚型是腺癌(46%),在石棉接触患者中占71%。研究组中最常见的初始东部肿瘤协作组(ECOG)体能状态评分为1分(24例患者,48%),初始分期为IV期(25例患者,50%)。在中位15个月(1 - 96个月)的随访期内:1年总生存率(OS)为68%,2年总生存率为36%,中位生存时间为19个月。单因素分析显示,ECOG体能状态差、晚期、诊断时贫血和体重减轻是不良预后因素。然而,腺癌亚型是一个良好的预后因素。

结论

在本研究中,NSCLC亚型、ECOG体能状态评分差、晚期、贫血和体重减轻是土耳其女性肺癌的预后因素。

相似文献

1
Lung cancer in women: a single institution experience with 50 patients.女性肺癌:一家机构对50例患者的经验
Asian Pac J Cancer Prev. 2014;15(1):151-4. doi: 10.7314/apjcp.2014.15.1.151.
2
Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.根据美国癌症联合委员会(AJCC)第7版分期系统,T4 N0-3期非小细胞肺癌患者的生存结果及预后因素
Asian Pac J Cancer Prev. 2014;15(6):2465-72. doi: 10.7314/apjcp.2014.15.6.2465.
3
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.EGFR 突变阳性的晚期非小细胞肺癌患者一线使用吉非替尼治疗的总生存预后因素的真实世界数据。
Oncologist. 2017 Sep;22(9):1075-1083. doi: 10.1634/theoncologist.2016-0331. Epub 2017 May 15.
4
Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.体能状态和吸烟状态是非小细胞肺癌生存的独立有利预后因素:对 26957 例非小细胞肺癌患者的综合分析。
J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9.
5
The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.晚期非小细胞肺癌患者临床预后因素与表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)疗效的相关性:94例EGFR突变患者的回顾性评估
Oncotarget. 2017 Jan 10;8(2):3412-3421. doi: 10.18632/oncotarget.13787.
6
Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India.全印医学科学研究所肺癌的临床病理特征:印度的一种转变模式
Asian Pac J Cancer Prev. 2013;14(1):489-94. doi: 10.7314/apjcp.2013.14.1.489.
7
[Lung cancer in women: clinical features and factors related to survival].[女性肺癌:临床特征及与生存相关的因素]
Tuberk Toraks. 2008;56(3):266-74.
8
Lung cancer in women, a different disease: survival differences by sex in Turkey.女性肺癌:一种不同的疾病——土耳其肺癌患者的性别生存差异
Asian Pac J Cancer Prev. 2015;16(2):815-22. doi: 10.7314/apjcp.2015.16.2.815.
9
Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.在完全切除的IIA-IIIA期非小细胞肺癌患者中,肿瘤囊外扩展是一个有力的预后因素。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11268-77. eCollection 2015.
10
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.非小细胞肺癌患者的脑膜转移癌:对生存的影响及相关预后因素。
J Thorac Oncol. 2013 Feb;8(2):185-91. doi: 10.1097/JTO.0b013e3182773f21.

引用本文的文献

1
Immunohistochemical and Electron Microscopy Evolution in the Diagnosis of Lung Cancer in Iraq.伊拉克肺癌的免疫组化和电子显微镜诊断演变。
Arch Razi Inst. 2022 Feb 28;77(1):95-100. doi: 10.22092/ARI.2021.356552.1870. eCollection 2022 Feb.
2
An immune-related nomogram model that predicts the overall survival of patients with lung adenocarcinoma.预测肺腺癌患者总生存期的免疫相关列线图模型。
BMC Pulm Med. 2022 Mar 30;22(1):114. doi: 10.1186/s12890-022-01902-6.
3
Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
基于癌症基因组图谱数据库,利用人工神经网络探索肺腺癌的生存预后。
Medicine (Baltimore). 2019 May;98(20):e15642. doi: 10.1097/MD.0000000000015642.
4
Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005-2008.黎巴嫩 2005-2008 年期间按性别和组织学类型划分的肺癌发病率趋势。
J Epidemiol Glob Health. 2017 Sep;7(3):161-167. doi: 10.1016/j.jegh.2017.04.003. Epub 2017 Apr 29.
5
Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.晚期非小细胞肺癌患者长期生存的预后因素。
Ann Transl Med. 2016 May;4(9):161. doi: 10.21037/atm.2016.05.13.
6
The incidence and mortality of lung cancer and their relationship to development in Asia.亚洲地区肺癌的发病率和死亡率及其与发展的关系。
Transl Lung Cancer Res. 2015 Dec;4(6):763-74. doi: 10.3978/j.issn.2218-6751.2015.12.01.